MedTrace Logo

Ginger for Colorectal Cancer Prevention

NCT01344538 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-08-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if ginger root extract when taken daily for 28 days is able to decrease levels of inflammatory chemicals called eicosanoids in the gut tissue of people who are at normal risk and those at increased of developing colorectal cancer compared to people taking placebo.

Conditions

Interventions

DRUG

Ginger Root Extract (Pure Encapsulations)

2.0 g per day (10:1 extract)

DIETARY_SUPPLEMENT

Placebo Capsule

2.0 g per day

Sponsors & Collaborators

Principal Investigators

  • Suzanna M Zick, ND, MPH · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2011-05-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344538 on ClinicalTrials.gov